SG Americas Securities’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$337K	Buy	20,468 +3,189	+18%	+$61K	﹤0.01%	2397
2025 Q4	$271K	Buy	+17,279	New	+$233K	﹤0.01%	2803
2025 Q1	–	Sell	-16,742	Closed	-$116K	–	3574
2024 Q4	$116K	Buy	16,742 +6,323	+61%	+$47.4K	﹤0.01%	2617
2024 Q3	$55K	Buy	+10,419	New	+$52.6K	﹤0.01%	3226
2024 Q1	–	Sell	-12,257	Closed	-$69K	–	3149
2023 Q4	$69K	Sell	12,257 -1,609	-12%	-$6.31K	﹤0.01%	2861
2023 Q3	$66K	Buy	+13,866	New	+$89.3K	﹤0.01%	2883
2023 Q2	–	Sell	-13,411	Closed	-$104K	–	2618
2023 Q1	$104K	Buy	13,411 +2,779	+26%	+$19.3K	﹤0.01%	2885
2022 Q4	$81K	Buy	+10,632	New	+$88.6K	﹤0.01%	2773
2022 Q3	–	Sell	-11,319	Closed	-$109K	–	3318
2022 Q2	$109K	Buy	+11,319	New	+$114K	﹤0.01%	3073
2022 Q1	–	Sell	-6,621	Closed	-$135K	–	3150
2021 Q4	$135K	Sell	6,621 -617	-9%	-$12.9K	﹤0.01%	2887
2021 Q3	$161K	Buy	+7,238	New	+$207K	﹤0.01%	3381